Kyorin Europe GmbH opens its doors for business
March 11, 2002
On March 8,11:30am local time, an opening ceremony was performed and business commenced for Kyorin Europe GmbH, located in Frankfurt, Germany, as a base for business development in Europe. Kyorin Europe GmbH is a wholly-owned subsidiary of Kyorin Pharmaceutical co., Ltd (President: Ikuo Ogihara)
In Europe, Kyorin Pharmaceutical has licensed out its proprietary drugs, including Gatifloxacin, Norfloxacin and HES to its local partners. Currently, Kyorin's licensing partners are conducting clinical trials of our diabetes agent KRP-297 and intravenous Gatifloxacin.
Adobe Reader software is required to view and print PDF files. The latest version of Adobe Reader can be downloaded by accessing the Adobe Systems Incorporated website.